MeSH term
Frequency | Condition_Probility | Humans | 29 | 0.0 |
Molecular Sequence Data | 12 | 0.0 |
Reference Values | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 3 | 0.0 |
Tissue Kallikreins/*genetics | 3 | 25.0 |
Amino Acid Sequence | 8 | 0.0 |
Animals | 5 | 0.0 |
Cells, Cultured | 2 | 0.0 |
Aged | 7 | 0.0 |
Aged, 80 and over | 4 | 0.0 |
Female | 13 | 0.0 |
*Gene Expression | 3 | 0.0 |
Kallikreins/*biosynthesis/genetics | 3 | 33.0 |
Male | 12 | 0.0 |
Middle Aged | 7 | 0.0 |
Research Support, Non-U.S. Gov't | 20 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Base Sequence | 9 | 0.0 |
Chromosome Mapping | 6 | 0.0 |
Chromosomes, Human, Pair 19 | 2 | 1.0 |
Comparative Study | 3 | 0.0 |
Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Phylogeny | 2 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Kallikreins/*genetics | 9 | 36.0 |
*Multigene Family | 2 | 0.0 |
*Chromosomes, Human, Pair 19 | 6 | 1.0 |
Alleles | 3 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
Adolescent | 3 | 0.0 |
Adult | 6 | 0.0 |
Immunohistochemistry | 2 | 0.0 |
Receptor, Bradykinin B2 | 2 | 9.0 |
DNA | 2 | 0.0 |
Expressed Sequence Tags | 2 | 0.0 |
Prostate-Specific Antigen/*genetics | 2 | 10.0 |
*Evolution, Molecular | 2 | 0.0 |
Mice | 3 | 0.0 |
Prostatic Neoplasms/genetics | 2 | 4.0 |
Rats | 2 | 0.0 |
Gene Frequency | 3 | 0.0 |
Genotype | 3 | 0.0 |
Kidney/*enzymology | 3 | 4.0 |
Kidney/metabolism | 2 | 0.0 |
Nephrectomy | 2 | 2.0 |
Genetic Markers | 5 | 0.0 |
*Polymorphism, Genetic | 2 | 0.0 |
Blotting, Southern | 5 | 0.0 |
Polymerase Chain Reaction | 6 | 0.0 |
Tissue Kallikreins | 4 | 8.0 |
Blotting, Northern | 3 | 0.0 |
Gene Expression | 3 | 0.0 |
Oligonucleotide Probes | 2 | 0.0 |
Conserved Sequence | 2 | 0.0 |
Polymorphism, Restriction Fragment Length | 2 | 0.0 |
Kallikreins/genetics | 3 | 42.0 |
*Chromosome Mapping | 2 | 0.0 |
*Polymorphism, Restriction Fragment Length | 2 | 0.0 |
Pedigree | 2 | 0.0 |
Linkage (Genetics) | 2 | 0.0 |
